Most read article(s)

Research Article
Cryptococcal Meningitis Reported With Fingolimod TreatmentCase Series
Maurizio Del Poeta, Brian J. Ward, Benjamin Greenberg, et al.

March 22, 2022
Article
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
Katerina Karagiorgou, Maria Dandoulaki, Renato Mantegazza, et al.

March 29, 2022
Article
New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD
Yukio Takeshita, Susumu Fujikawa, Kenichi Serizawa, et al.

October 19, 2021
Views & Reviews
COVID-19 Among Patients With Multiple SclerosisA Systematic Review
Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.

May 20, 2021
Views & Reviews
IgG4-Mediated Neurologic AutoimmunitiesUnderstanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
Marinos C. Dalakas

November 29, 2021
Article
Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation
Ekaterina Esaulova, Claudia Cantoni, Irina Shchukina, et al.

May 05, 2020
Article
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor, Giulio Disanto, Daniel R. Altmann, et al.

October 01, 2015
Article
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
Andrea Ines Ciplea, Annette Langer-Gould, Annick de Vries, et al.

April 23, 2020
Article
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.

November 16, 2021
Article
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
Michael Dietrich, Christina Hecker, Elodie Martin, et al.

March 30, 2022

Pages